ONO Implements Oracle's CTMS for Global Centralized Management of Clinical Trials
Oracle News, Friday, March 15th, 2024
Streamlining processes, such as clinical trial progress management, monitoring information management, and quality assurance, for consistent information management and rapid decision-making on a global scale
Oracle Corporation Japan (Headquarters: Minato-ku, Tokyo; President: Toshimitsu Misawa) announced that ONO PHARMACEUTICAL CO., LTD. (Headquarters: Chuo-ku, Osaka; President and CEO: Gyo Sagara, 'ONO') implemented Oracle's Clinical Trial Management System (CTMS) Cloud Service as an IT platform for clinical trials as part of ONO's digital transformation (DX) strategy. The implementation of this system enables the centralized management of clinical trial information and monitoring activities globally and is expected to significantly reduce the system management workload compared to before implementation.